Mulherin DM - Search Results

1

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Kingsley GH, Kowalczyk A, Taylor H, Ibrahim F, Packham JC, McHugh NJ, Mulherin DM, Kitas GD, Chakravarty K, Tom BD, O'Keeffe AG, Maddison PJ, Scott DL. Kingsley GH, et al. Among authors: mulherin dm. Rheumatology (Oxford). 2012 Aug;51(8):1368-77. doi: 10.1093/rheumatology/kes001. Epub 2012 Feb 17. Rheumatology (Oxford). 2012. PMID: 22344575 Free PMC article. Clinical Trial.

2

Sulphonamide-induced remission in rheumatoid arthritis--a thought-provoking prescribing error.

Popplewell M, Mulherin D. Popplewell M, et al. Rheumatology (Oxford). 2013 Mar;52(3):578-9. doi: 10.1093/rheumatology/kes154. Epub 2012 Jul 24. Rheumatology (Oxford). 2013. PMID: 22831966 No abstract available.

3

Multiple malignant melanomas in a patient with RA treated with methotrexate.

Potter T, Hardwick N, Mulherin D. Potter T, et al. J Rheumatol. 1998 Nov;25(11):2282-3. J Rheumatol. 1998. PMID: 9818680 No abstract available.

4

Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ.

Mulherin D, Fitzgerald O, Bresnihan B. Mulherin D, et al. Br J Rheumatol. 1996 Dec;35(12):1263-8. doi: 10.1093/rheumatology/35.12.1263. Br J Rheumatol. 1996. PMID: 9010054

5

Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis.

Mulherin D, Bresnihan B, FitzGerald O. Mulherin D, et al. J Rheumatol. 1995 Jun;22(6):1211-2. J Rheumatol. 1995. PMID: 7674263 No abstract available.

6

Methotrexate pneumonitis in rheumatoid arthritis--a dramatic response to treatment.

Mulherin D, Cummiskey JM, Doyle GD, FitzGerald O. Mulherin D, et al. Br J Rheumatol. 1992 May;31(5):356-7. doi: 10.1093/rheumatology/31.5.356. Br J Rheumatol. 1992. PMID: 1581781 No abstract available.

7

The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures.

Mulherin D, Skelly M, Saunders A, McCarthy D, O'Donoghue D, Fitzgerald O, Bresnihan B, Mulcahy H. Mulherin D, et al. J Rheumatol. 1996 Feb;23(2):237-40. J Rheumatol. 1996. PMID: 8882025

8

Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres.

Smith N, Gadsby K, Butt S, Carruthers D, Deeming A, Ledingham J, Fletcher M, Mulherin D, Roskell S, Kay L, Nicholl K, Cooper R, Worsley A, Deighton C. Smith N, et al. Rheumatology (Oxford). 2007 Oct;46(10):1557-9. doi: 10.1093/rheumatology/kem188. Epub 2007 Jul 31. Rheumatology (Oxford). 2007. PMID: 17666440

9

The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.

Harrison MJ, Hassell A, Dawes PT, Scott DL, Knight SM, Davis MJ, Mulherin D, Symmons DP. Harrison MJ, et al. Rheumatology (Oxford). 2007 May;46(5):849-55. doi: 10.1093/rheumatology/kel445. Epub 2007 Jan 30. Rheumatology (Oxford). 2007. PMID: 17264089 Clinical Trial.

10

Conservative hand therapy treatments in rheumatoid arthritis--a randomized controlled trial.

O'Brien AV, Jones P, Mullis R, Mulherin D, Dziedzic K. O'Brien AV, et al. Rheumatology (Oxford). 2006 May;45(5):577-83. doi: 10.1093/rheumatology/kei215. Epub 2005 Nov 30. Rheumatology (Oxford). 2006. PMID: 16319099 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results